Author

Miharu Kubo

Tokyo University of Pharmacy and Life Sciences

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Hidetoshi SakuraiiD· 1 shared Liyang Ni· 1 shared Makoto ShimizuiD· 1 shared Mariko Matsuto· 1 shared Ryuichiro SatoiD· 1 shared Xiaolin ZhaoiD· 1 shared Yoshio YamauchiiD· 1 shared Yu TakahashiiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Hidetoshi SakuraiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Modeling statin-induced myopathy with human iPSCs reveals that impaired proteostasis underlies the myotoxicity and is targetable for the prevention

Xiaolin Zhao, Liyang Ni, Miharu Kubo, Mariko Matsuto, Hidetoshi Sakurai, Makoto Shimizu, Yu Takahashi, Ryuichiro Sato, Yoshio Yamauchi

This study uses human iPSC-derived myocytes to model statin-induced myopathy, showing statins impair proteostasis via the mevalonate pathway and identify FOXO1 as a target for prevention.

American Journal of Physiology-Cell Physiology · Mar 8, 2025Peer-reviewedPharmacology & Toxicology